Tao Song Feng

Dr. Tao Song Feng


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
TFTao Song Feng
Tao Song Feng
YYYang Yang
Yang Yang
JYJin-Fei Yang
Jin-Fei Yang
YGYue-Ming Gao
Yue-Ming Gao
JCJing-Yuan Cao
Jing-Yuan Cao
BLBi-Cheng Liu
Bi-Cheng Liu
Urinary sediment messenger RNAs (mRNAs) have been shown as novel biomarkers of kidney disease. We aimed to identify targeted urinary mRNAs in diabetic nephropathy (DN) based on bioinformatics analysis and clinical validation. Microarray studies of DN were searched in the GEO database and Nephroseq platform. Gene modules negatively correlated with estimated glomerular filtration rate (eGFR) were identified by informatics methods. Hub genes were screened within the selected modules. In validation cohorts, a quantitative polymerase chain reaction assay was used to compare the expression levels of candidate mRNAs. Patients with renal biopsy–confirmed DN were then followed up for a median time of 21 months. End-stage renal disease (ESRD) was defined as the primary endpoint. Multivariate Cox proportional hazards regression was developed to evaluate the prognostic values of candidate mRNAs. Bioinformatics analysis revealed four chemokines (CCL5, CXCL1, CXLC6 and CXCL12) as candidate mRNAs negatively correlated with eGFR, of which CCL5 and CXCL1 mRNA levels were upregulated in the urinary sediment of patients with DN. In addition, urinary sediment mRNA of CXCL1 was negatively correlated with eGFR (r = −0.2275, P = 0.0301) and CCL5 level was negatively correlated with eGFR (r = −0.4388, P < 0.0001) and positively correlated with urinary albumin:creatinine ratio (r = 0.2693, P = 0.0098); also, CCL5 and CXCL1 were upregulated in patients with severe renal interstitial fibrosis. Urinary sediment CCL5 mRNA was an independent predictor of ESRD [hazard ratio 1.350 (95% confidence interval 1.045–1.745)]. Urinary sediment CCL5 and CXCL1 mRNAs were upregulated in DN patients and associated with a decline in renal function and degree of renal interstitial fibrosis. Urinary sediment CCL5 mRNA could be used as a potential prognostic biomarker of DN.

8 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HZHui Zhang
Hui Zhang
SYShufang Yang
Shufang Yang
HWHongxiao Wang
Hongxiao Wang
HFHuzaifa Fareeduddin Mohammmed Farooqui
Huzaifa Fareeduddin Mohammmed Farooqui
WZWenwen Zhu
Wenwen Zhu
HZHaoqiang Zhang
Haoqiang Zhang
Background and aims Diabetic peripheral neuropathy (DPN) and diabetic nephropathy (DN) both have microcirculation dysfunction. Urinary albumin-to-creatinine ratio (UACR) is a biomarker for DN. We aimed to explore the links between DPN and UACR in patients with type 2 diabetes mellitus (T2DM). Methods A total of 195 T2DM patients were defined as Control or DPN group. Clinical parameters were compared, and the association between HbA1c (or UACR) and DPN was analyzed. Risk factors for DPN were observed, and the diagnostic values of HbA1c and UACR were assessed. Results Compared with 104 participants without DPN, 91 individuals with DPN exhibited higher HbA1c and UACR levels. In all patients, increased HbA1c and UACR were identified as risk factors for DPN in individuals with T2DM. Moreover, increased HbA1c was a risk factor for DPN in volunteers without DN, whereas elevated UACR was determined as a risk factor for DPN in participants with DN. The cut-off point for HbA1c (7.65%) in patients without DN had a sensitivity of 86.0% and specificity of 44.6%, while the cut-off point for UACR (196.081 mg/g) in patients with DN had a sensitivity of 52.9% and specificity of 76.2%. Conclusion Elevated HbA1c and UACR levels are risk factors for DPN and may serve as potential biomarkers for DPN in T2DM patients.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YGYueming Gao
Yueming Gao
BWBin Wang
Bin Wang
JCJing-yuan Cao
Jing-yuan Cao
TFTao Song Feng
Tao Song Feng
BLBi-Cheng Liu
Bi-Cheng Liu
Objective. Lupus nephritis (LN) is a major and severe complication of systemic lupus erythematosus (SLE). Neutrophil gelatinase‐associated lipocalin (NGAL), as a promising next‐generation biomarker in clinical nephrology, has received extensive attention. However, its diagnostic performance in LN has high variability. Therefore, we performed an updated meta‐analysis to further evaluate the diagnostic accuracy of urinary NGAL (uNGAL). Materials and Methods. PubMed, Embase, and Cochrane Library were searched from inception to October 27, 2019. Meta‐analysis was performed with a bivariate random effects model. Additionally, the summary receiver operating characteristic (SROC) curves were established. The sources of heterogeneity were explored by meta‐regression, subgroup analysis, and sensitivity analysis. Publication bias was assessed using the Deeks test. Results. 19 articles consisting of 21 eligible studies were included. In diagnosing LN, the estimates (95% confidence interval (CI)) were as follows: sensitivity, 0.84 (0.71‐0.91); specificity, 0.91 (0.70‐0.98); and the SROC‐AUC value, 0.92 (0.90‐0.94). In identifying active LN, the estimates were as follows: sensitivity, 0.72 (0.56‐0.84); specificity, 0.71 (0.51‐0.84); and the AUC value, 0.77 (0.74‐0.81). With respect to predicting renal flare, the estimates were as follows: sensitivity, 0.80 (0.57‐0.92); specificity, 0.67 (0.58‐0.75); and the AUC value, 0.74 (0.70‐0.78). For the studies to distinguish proliferative LN, the estimates were as follows: sensitivity, 0.87 (0.66‐0.97), and specificity, 0.69 (0.39‐0.91). Deeks’ funnel plot suggested that there was no significant publication bias. Conclusions. Our meta‐analysis indicates that uNGAL was a useful biomarker for diagnosis, estimation of activity, and prediction of renal flare of LN. In addition, the usefulness of uNGAL to distinguish pathological types of LN needs to be further investigated.

16 July 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
YCYafen Chu
Yafen Chu
HYHongping Yao
Hongping Yao
NLNi Lu
Ni Lu
YCYu Chang
Yu Chang
JWJumei Wang
Jumei Wang
HZHui Zhang
Hui Zhang
Aim: The triglyceride glucose-body mass index (TyG-BMI) is correlated not only to the onset of diabetic kidney disease (DKD) associated with nutrition (including glucose and triglyceride) metabolism but also incorporates body mass index (BMI), potentially serving as an indicator of non-alcoholic fatty liver disease (NAFLD). But, the links between TyG-BMI and DKD in individuals with and without NAFLD remains further exploration. Therefore, this present research aims to investigate the relationship between TyG-BMI and DKD in these patient groups and to evaluate its diagnostic value for DKD.Methods: A total of 425 individuals diagnosed with type 2 diabetes mellitus (T2DM) were categorized into the DKD group or the Control group. Clinical indicators were compared in these two groups, and the relationships between TyG-BMI and either the estimated glomerular filtration rate (eGFR) or the urinary albumin-to-creatinine ratio (UACR) were examined. Risk factors for DKD were examined, and the diagnostic value of TyG-BMI was assessed in patients without and with NAFLD.Results: Compared to 288 participants without DKD, 137 individuals with DKD exhibited higher TyG-BMI levels. In all individuals with T2DM, a higher TyG-BMI was recognized as a contributing factor to the development of DKD. Notably, this association was observed in patients without NAFLD, while no such link was established in those diagnosed with NAFLD. For T2DM patients lacking NAFLD, the TyG-BMI threshold of 49.2415 demonstrated a sensitivity of 91.3% and a specificity of 70.1%.Conclusion: Increased TyG-BMI values are associated with a higher risk of DKD and could act as potential indicators of DKD in individuals with T2DM.

29 June 2023 in Clinical and Translational Medicine
Verified
Journal Article
Open access
YGYueming Gao
Yueming Gao
ZSZhi Shang
Zhi Shang
SNSheng Nie
Sheng Nie
TFTao Song Feng
Tao Song Feng
BWBin Wang
Bin Wang
BLBi-Cheng Liu
Bi-Cheng Liu

29 August 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
ZSZhi Shang
Zhi Shang
HZHai-Dong Zhang
Hai-Dong Zhang
HQHui Qian
Hui Qian
YGYue-Ming Gao
Yue-Ming Gao
TFTao Song Feng
Tao Song Feng
Aims: This study aimed to investigate the associations between three systemic inflammatory indices, including the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV), and the risk of renal function decline in patients with type 2 diabetes mellitus (T2DM).Methods: We consecutively enrolled 9,537 patients with T2DM hospitalized at Peking University Third Hospital. The systemic inflammatory indices were calculated from baseline blood routine indicators. Renal function decline was defined as an estimated glomerular filtration rate decreasing by ≥ 40% from baseline. All participants were categorized into tertiles according to the systemic inflammatory indices. Restricted cubic spline (RCS) curves, multivariable Cox proportional hazard regression models, and receiver operating characteristic (ROC) curves were used for analysis.Results: A total of 1,495 outcome events were recorded during the follow-up. The RCS analysis suggested a non-linear association of systemic inflammatory indices with the risk of renal function decline (P for nonlinear < 0.001). Using the lowest tertile as reference, multivariate Cox regression revealed that patients in the highest tertile of the three systemic inflammatory indices had a significantly higher risk of renal function decline (SII: HR=1.67, 95% CI=1.47–1.91, P<0.001; SIRI:HR=1.69, 95% CI=1.46–1.95, P<0.001; PIV: HR=1.58, 95% CI=1.38–1.81, P<0.001). The ROC curves showed that the SIRI was better than other two indices at predicting renal function decline.Conclusion: A significantly positive association was shown between systemic inflammatory indices and the risk of renal function decline in T2DM patients. Among these inflammatory indices, SIRI has relatively high predictive performance for renal function decline.